STOCK TITAN

Integra Lifesciences Holdings Corp - IART STOCK NEWS

Welcome to our dedicated news page for Integra Lifesciences Holdings (Ticker: IART), a resource for investors and traders seeking the latest updates and insights on Integra Lifesciences Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Integra Lifesciences Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Integra Lifesciences Holdings's position in the market.

Rhea-AI Summary
Integra LifeSciences Holdings Corporation will release Q3 2023 financial results on October 25, 2023. Conference call at 8:30 a.m. ET. Webcast replay available on the Company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
conferences earnings
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. appoints Adam Hodges as VP of Sales and Marketing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
management AI
-
Rhea-AI Summary
Integra LifeSciences CFO to present at Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
-
Rhea-AI Summary
Integra LifeSciences Holdings Corporation will release its second quarter 2023 financial results on July 27, 2023. A conference call will be hosted by the management team at 8:30 a.m. ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary
Integra LifeSciences completes patient enrollment in the DuraSorb U.S. IDE clinical study for two-stage breast reconstruction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.89%
Tags
Integra Lifesciences Holdings Corp

Nasdaq:IART

IART Rankings

IART Stock Data

2.58B
67.22M
13.81%
88.65%
2.66%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Princeton

About IART

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li